Focus & mood

The review found preliminary support for therapies that directly address trauma in people who also have a psychotic disorder. Improvements were reported for trauma symptoms and for psychosis symptoms, with some indications that improvements persisted. Depression, anxiety and social functioning remained uncertain, and methodological problems limit how firmly treatment effects can be established.

Keep in mind: The authors describe an early evidence base with methodological challenges. The abstract does not give comparator details, effect sizes or follow-up lengths, limiting assessment of the size and durability of any benefit.

The review identified several factors associated with mild cognitive impairment in people with diabetes, including older age, longer diabetes duration, less education, smoking, high blood pressure and cardiovascular disease. These findings describe who was more likely to have cognitive impairment in the included studies. They do not demonstrate that changing any factor would prevent it.

Keep in mind: Most studies involved Chinese participants. The abstract also omits reference groups, confidence intervals and measurement increments for the reported associations, limiting interpretation of their size and applicability to other populations.

For older adults who reported declining cognitive abilities, interventions combining several domains produced better memory and executive-function results than controls or nutrition-only interventions. Executive function means the mental skills used to organize and manage tasks. However, the control comparisons did not establish improvements in overall cognition or physical performance, and benefit sizes were not provided.

Keep in mind: The abstract does not describe the intervention components, treatment lengths, effect sizes or confidence intervals. These omissions limit judgments about how much participants improved and which combinations contributed to the results.

Among women with breast cancer, pooled controlled studies favored art therapy for anxiety and depression outcomes. The direction remained favorable when studies judged at high risk of bias were removed. However, the abstract does not identify the effect-size scale, making it difficult to translate the numerical results into understandable changes in symptoms.

Keep in mind: The studies used different art modalities and widely varying intervention lengths. The abstract does not describe control conditions, outcome scales or assessment schedules sufficiently to judge which approach produced the reported differences.

The review found no uniform change in burnout among postgraduate medical trainees during the pandemic. Emotional exhaustion was reported as stable, while depersonalisation, meaning emotional detachment, and personal accomplishment declined compared with earlier studies. These dimensions changed differently, and specialty and country patterns varied, so the pooled findings do not support a single verdict for all trainees.

Keep in mind: The abstract does not establish that identical trainees were followed across periods or explain the reference for its standardized effect values. The comparison cannot isolate the pandemic as the cause of differences.

The human evidence did not show a statistically significant improvement in overall cognition with curcumin compared with placebo. Subgroup analyses suggested improvements in working memory and processing speed, but these narrower findings do not establish a general cognitive benefit. Adverse events were more common with curcumin, adding uncertainty about its overall usefulness.

Keep in mind: The abstract omits human participants' ages, trial lengths, and adverse-event types or rates. It also does not identify which trials contributed to the cognitive subgroup findings.

Structured psychotherapy had the largest reported effects, particularly for depression. Mindfulness programs showed improvements in distress and emotional regulation, while coping and resilience programs showed smaller gains in adaptive coping. The abstract does not provide the numerical estimates or comparator details needed to judge practical importance or establish that one program is better than another.

Keep in mind: The abstract omits effect estimates, confidence intervals, comparison conditions and follow-up durations. Study results varied, partly with program type, delivery format and cancer subtype, which limits a single conclusion for all patients.

The review found a possible cognitive benefit for betahistine in people with schizophrenia, but the supporting result came from a single trial. Separate drugs showed improvements in depressive symptoms, also in individual studies. The other pooled drugs increased insomnia risk. These findings do not demonstrate a consistent benefit across the drug group.

Keep in mind: The favorable cognitive and depression findings each relied on an individual study. The abstract does not report treatment durations or translate score changes into everyday functioning.

Adults with chronic low back pain had slightly poorer overall cognitive performance than pain-free controls, based on low-certainty evidence. Differences also appeared in memory, executive function, motor skills and processing speed, but those findings were very uncertain. The review does not establish that chronic low back pain caused these differences or explain their origins.

Keep in mind: Certainty was low for overall cognition and very low for other abilities. Abstract-only access cannot establish how these test differences affected daily activities.

Among breast cancer survivors with elevated anxiety, online mindfulness training reduced anxiety scores compared with waiting for the program. Depression, fatigue, insomnia and cancer-related worry also improved after the intervention, while vasomotor symptom scores showed no clear change. The abstract does not establish how meaningful the average anxiety-score difference was in participants’ daily lives.

Keep in mind: The comparison was with a waitlist, so the abstract cannot show how mindfulness compares with another active program. It does not report whether the anxiety-score difference met a threshold for meaningful improvement.

Delusion severity and task-derived expectations about change decreased across both therapy groups. However, the study did not establish that changes in those expectations tracked clinical improvement. Reduced caudate activity tracked expectation changes, but no association with overall delusion scores was detected, leaving the proposed target's clinical relevance uncertain.

Keep in mind: The abstract does not report superiority of either therapy, and both included standard care. Brain imaging involved a subgroup, limiting interpretation of the proposed brain-based target.

Comparing Chinese-language and English-language publications, the analysis found that acupuncture research on cognitive impairment was concentrated in China, with different themes across the language groups. This describes where and how research is being done. It does not show that acupuncture improves memory, thinking or other clinical outcomes, or validate the proposed mechanisms.

Keep in mind: Publication counts and research themes are not treatment outcomes. The abstract does not report patient-level comparisons, clinical effect estimates or a synthesis of trial quality.

The review brings together evidence about changes in brain-cell activity and connections under chronic stress. It describes weakened connections and structural changes, but findings on whether key nerve cells become more or less active conflict. The abstract does not identify the studied populations, so these mechanisms cannot be translated directly into clinical outcomes.

Keep in mind: The abstract does not describe study selection, evidence quality or human versus animal contributions. It offers a mechanistic synthesis without effect estimates or clinical treatment comparisons.

The pilot found that both care models were acceptable, with safety described favorably in the abstract. BLEND participants had a greater reduction in suicidal thoughts, but the report gives no effect estimate or uncertainty interval. The study primarily tested whether the care model and a future effectiveness trial could be delivered.

Keep in mind: This small, unblinded pilot does not confirm effectiveness. The abstract reports no treatment duration, numerical between-group symptom effect, or detailed safety data, so the strength of the apparent advantage remains uncertain.

For young patients with future fertility intentions undergoing ovarian cyst surgery for endometriosis, music therapy did not produce statistically significant improvements in postoperative pain or anxiety compared with control. Although the authors suggest it might be an additional intervention, the reported results do not demonstrate benefit in this specific surgical population.

Keep in mind: The abstract supplies p-values without effect sizes or confidence intervals and does not describe the music schedule or control care. Nonsignificant comparisons cannot establish that the treatments were equivalent.

In adolescents who were not seeking clinical help, the mindfulness program did not show benefits on self-reported stress, anxiety, depression, mood or emotion-regulation strategies compared with waiting. Participants nevertheless reported high satisfaction. The result concerns this program and population; it does not establish that mindfulness has no effects, and later outcomes remain untested.

Keep in mind: This abstract-based account relies on self-reported outcomes. Individual responses varied, longer-term effects were not investigated, and the reported assessment interval is not clearly reconciled with the stated program length.

Among Chinese patients receiving maintenance hemodialysis, five-element music was associated with lower depression questionnaire scores than Western music in this randomized trial. Differences in sleep quality and symptom-related distress were not statistically significant. The abstract leaves the timing of the depression estimate unclear and contains inconsistencies that prevent a confident interpretation of some other mood findings.

Keep in mind: Some anxiety and positive-emotion estimates conflict with their confidence limits. The abstract does not identify the assessment time for the depression comparison or describe control-group care.

Among older adults with cognitive complaints, mild impairment or Alzheimer's disease, meditation improved overall thinking-test scores compared with controls. Sleep quality and general health questionnaire scores also improved, while depression scores did not show a statistically significant difference. Differences between studies and limited sample sizes make the pooled results uncertain, particularly for individual diagnostic groups.

Keep in mind: The authors identify differences between studies and limited sample sizes. The abstract does not report treatment schedules, follow-up lengths or separate effects for each cognitive condition.

Exercise interventions were linked to improved cognitive test performance in controlled studies of older adults. The review also reported increased blood-flow velocity in a major brain artery and an association between brain blood flow and cognition. However, that association does not establish that blood-flow changes caused the cognitive improvements or that exercise delayed clinical cognitive decline.

Keep in mind: The abstract does not describe age ranges, exercise protocols, comparator activities, or follow-up lengths. It also omits units for the artery-velocity estimate, limiting interpretation of the physical change in this abstract-based account.

Among distressed cancer survivors, both mindfulness-based recovery and Tai Chi/Qigong improved overall mood scores more than their respective waitlists after the program. Receiving a preferred program did not show a statistically significant effect on outcomes. That result does not establish that choosing and random assignment are equivalent, or that either program outperforms the other.

Keep in mind: Program length, exact mood-score differences and confidence intervals were absent from the abstract, limiting assessment of the size and persistence of improvement.

Across the reviewed accounts, people recovering from stress-related disorders valued an engaging, authentic environment, opportunities to regain hope and a sense of agency, and room for personal growth. These themes describe what participants experienced as supportive. They do not show how much a particular service improves recovery or establish that it causes improvement.

Keep in mind: The abstract does not describe participant numbers, settings or differences between included studies. It also supplies no comparative recovery outcomes for evaluating the proposed clinical activities.

In studies involving cancer patients with cancer-related thinking difficulties, donepezil did not produce statistically significant improvements on the assessed cognitive tests. Fatigue also showed no statistically clear improvement. The review therefore did not establish benefit for these measured outcomes, but missing effect estimates and uncertainty ranges prevent a precise account of what benefit remains possible.

Keep in mind: Without effect estimates or confidence intervals, the abstract cannot show the range of possible benefit. It also does not describe cancer types, treatment histories or the duration of donepezil use.

In this small trial, healthy young men had faster responses and better ability to suppress interfering information on a color-word test after high-flavanol capsules than after low-flavanol capsules. Differences appeared at rest and during cycling with a prolonged cognitive task. The findings concern immediate test performance, rather than demonstrated improvements in sporting outcomes.

Keep in mind: This abstract-based result comes from a small, exclusively male sample and a single intake before a short laboratory protocol. It does not establish whether effects persist or apply to other populations.

In patients with Alzheimer's disease, pooled trials favored adding acupuncture to donepezil on several cognitive tests and scores concerning daily activities and behavior. These results describe differences on assessment scales, rather than evidence of reversing the disease. Treatment duration and adverse-event findings are absent from the abstract, and the authors seek larger, higher-quality trials.

Keep in mind: This abstract-based summary cannot assess the durability or safety of the combination. Adverse events were listed as an outcome, but no safety results were reported; stronger randomized evidence was explicitly requested.